Shareholders Equity and Dividend Restrictions (Tables)

12 Months Ended

Dec. 31, 2022

Equity [Abstract]

Statutory Net Income and Net Assets of the Company's Subsidiaries

The statutory net income of the Company's life, accident and health insurance and HMO subsidiaries for the years ended, and their statutory surplus as of December 31 were as follows:

(In billions)	2022		2021		2020
Net income	$	5.7	$	3.4	$	4.0
Surplus	$	16.4	$	13.3	$	12.9

These amounts, including restricted GAAP net assets of the Company's subsidiaries, were as follows:

(In billions)	December 31, 2022
Minimum statutory surplus required by regulators (1)	$	4.2
Investments on deposit with regulatory bodies	$	0.3
Maximum dividend distributions permitted in 2023 without regulatory approval	$	3.2
Maximum loans to the parent company permitted without regulatory approval	$	1.4
Restricted GAAP net assets of The Cigna Group's subsidiaries	$	14.8

(1) Excludes amounts associated with foreign operated equity method joint ventures.